MENU
+Compare
MIST
Stock ticker: NASDAQ
AS OF
Nov 13 closing price
Price
$1.90
Change
-$0.03 (-1.55%)
Capitalization
161.06M

MIST Milestone Pharmaceuticals Forecast, Technical & Fundamental Analysis

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines... Show more

MIST
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for MIST with price predictions
Nov 12, 2025

MIST's Stochastic Oscillator reaches into overbought zone

The Stochastic Oscillator for MIST moved into overbought territory on November 12, 2025. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

MIST moved below its 50-day moving average on October 28, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for MIST crossed bearishly below the 50-day moving average on October 30, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 21 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MIST declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MIST entered a downward trend on November 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MIST's RSI Indicator exited the oversold zone, of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 11, 2025. You may want to consider a long position or call options on MIST as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MIST just turned positive on November 12, 2025. Looking at past instances where MIST's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MIST advanced for three days, in of 266 cases, the price rose further within the following month. The odds of a continued upward trend are .

MIST may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.960) is normal, around the industry mean (24.439). P/E Ratio (0.000) is within average values for comparable stocks, (63.753). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.001). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (74.074) is also within normal values, averaging (322.723).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MIST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MIST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
MIST
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

MIST is expected to report earnings to rise 48.33% to -17 cents per share on March 31

Milestone Pharmaceuticals MIST Stock Earnings Reports
Q4'25
Est.
$-0.18
Q3'25
Beat
by $0.04
Q2'25
Missed
by $0.02
Q1'25
Missed
by $0.11
Q4'24
Missed
by $0.03
The last earnings report on November 12 showed earnings per share of -11 cents, beating the estimate of -15 cents. With 2.53M shares outstanding, the current market capitalization sits at 161.06M.
A.I. Advisor
published General Information

General Information

a developer and manufacturer of cardiovascular medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1111 Dr. Frederik-Philips Boulevard
Phone
+1 514 336-0444
Employees
47
Web
https://www.milestonepharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WOLTF112.204.06
+3.76%
Wolters Kluwer N.V.
HAIIF3.23N/A
N/A
Haitian International Holdings Ltd
MCRUF2.61N/A
N/A
Morgan Advanced Materials PLC
HWIN1.75N/A
N/A
Hometown International, Inc.
ESIFF0.15-0.01
-3.67%
AI ARTIFICIAL INTELLIGENCE VENTURES INC.

MIST and Stocks

Correlation & Price change

A.I.dvisor tells us that MIST and AKBA have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MIST and AKBA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIST
1D Price
Change %
MIST100%
+1.05%
AKBA - MIST
33%
Poorly correlated
+2.21%
GYRE - MIST
29%
Poorly correlated
+4.12%
PRAX - MIST
29%
Poorly correlated
+0.03%
OSRH - MIST
29%
Poorly correlated
+4.76%
KYTX - MIST
28%
Poorly correlated
+4.71%
More